Disc Medicine (IRON) Amortizatization of Intangibles (2024 - 2026)
Disc Medicine (IRON) posted quarterly Amortizatization of Intangibles of $489000.0 for Q2 2026, down 81.34% year-over-year from $2.6 million in Q2 2025, and down 54.26% quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Disc Medicine (IRON) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Amortizatization of Intangibles for 3 consecutive years, with $489000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 81.34% year-over-year to $489000.0; the TTM figure through Jun 2026 stood at $4.9 million (down 49.99% YoY), while the FY2025 annual figure was $8.5 million, up 60.61% from the prior year.
- Amortizatization of Intangibles declined to $489000.0 in Q2 2026 per IRON's latest filing, from $1.1 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.6 million in Q2 2025 and bottomed at $489000.0 in Q2 2026.
- Historically, Amortizatization of Intangibles has averaged $1.7 million across 3 years, with a median of $1.7 million in 2025.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles jumped 339.77% — and 2026, when it tumbled 81.34%.
- Disc Medicine's Amortizatization of Intangibles stood at $2.2 million in 2024, then fell by 26.22% to $1.6 million in 2025, then tumbled by 70.04% to $489000.0 in 2026.
- Business Quant data shows IRON's Amortizatization of Intangibles at $489000.0 in Q2 2026, $1.1 million in Q1 2026, and $1.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - | 489,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 489,000.00 |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 596,000.00 |